XORTX THERAPEUTICS INC (XRTX:NASDAQ)
$1.42 -0.14 (-8.9744%)
Analysed XORTX THERAPEUTICS INC (XRTX:NASDAQ) News Sources
XORTX Announces Closing of US$5 Million Public Offering
19-05-2026
yahoo.com
XORTX Announces Election to Voluntary Delist from the TSX Venture Exchange
12-06-2026
yahoo.com
XORTX Provides Corporate Update and Announces Appointment of Mika Grasso as Co-CEO
15-06-2026
yahoo.com
XORTX Appoints New Director
29-07-2026
yahoo.com
XORTX Announces Director Resignation
31-07-2026
yahoo.com
XORTX Announces Planned FDA IND Submission for XRx-026 Gout Program Using XORLO™, Targeting USD$700M+ U.S. Gout Market Opportunity
18-09-2026
yahoo.com
XORTX Outlines Anticipated Health Canada Clinical Trial Application for XRx-026 for Gout
08-10-2026
yahoo.com
XORTX Announces Termination and Postponement of Investor Relations Program
28-08-2026
yahoo.com
XORTX Re-Engages Investor Relations Program
08-09-2026
yahoo.com
XORTX Announces Initiation of Clinical and Commercial Manufacturing of XORLO™
10-09-2026
yahoo.com
What is the current price of XORTX THERAPEUTICS INC (XRTX:NASDAQ)?
The current price of XORTX THERAPEUTICS INC (XRTX:NASDAQ) is $1.42.
XORTX THERAPEUTICS INC (XRTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of XORTX THERAPEUTICS INC (XRTX:NASDAQ) since the previous trading day is $-0.14.
XORTX THERAPEUTICS INC (XRTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of XORTX THERAPEUTICS INC (XRTX:NASDAQ) since the previous trading day is -8.9744%.
What is the most recent average sentiment score for XORTX THERAPEUTICS INC (XRTX:NASDAQ)?
The most recent average sentiment score for XORTX THERAPEUTICS INC (XRTX:NASDAQ) is 53 out of 100.
What is the most recent average sentiment for XORTX THERAPEUTICS INC (XRTX:NASDAQ)?
The most recent sentiment for XORTX THERAPEUTICS INC (XRTX:NASDAQ) is .
SEC-8K** Filing Available For XORTX THERAPEUTICS INC (XRTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.